Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rosetta Genomics Ltd (ROSGQ)
OTHER OTC:ROSGQ
Rosetta Genomics (ROSGQ) Stock Price & Analysis
57 Followers
ROSGQ Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.00 - $0.04
Previous Close$0.02
Volume1.00
Average Volume (3M)N/A
Market Cap
$593.00
Enterprise Value$1.12M
Total Cash (Recent Filing)$1.32M
Total Debt (Recent Filing)$2.45M
Price to Earnings (P/E)N/A
Beta-1.84
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding5,929,860
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation13.00
R-Squared0.00649
Alpha1.87
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.20
Enterprise Value/Gross Profit0.63
Enterprise Value/Ebitda-0.08
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ownership Overview
15.88%
Insiders
0.00%
Mutual Funds
0.15% Other Institutional Investors
83.97% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
ROSGQ FAQ
What was Rosetta Genomics Ltd’s price range in the past 12 months?
Rosetta Genomics Ltd lowest stock price was $0.00 and its highest was $0.04 in the past 12 months.
What is Rosetta Genomics Ltd’s market cap?
Currently, no data Available
When is Rosetta Genomics Ltd’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Rosetta Genomics Ltd’s earnings last quarter?
Currently, no data Available
Is Rosetta Genomics Ltd overvalued?
According to Wall Street analysts Rosetta Genomics Ltd’s price is currently Overvalued.
Does Rosetta Genomics Ltd pay dividends?
Rosetta Genomics Ltd does not currently pay dividends.
What is Rosetta Genomics Ltd’s EPS estimate?
Rosetta Genomics Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rosetta Genomics Ltd have?
Rosetta Genomics Ltd has 5,930,000 shares outstanding.
What happened to Rosetta Genomics Ltd’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Rosetta Genomics Ltd?
Currently, no hedge funds are holding shares in ROSGQ
---
Company Description
Rosetta Genomics Ltd
Rosetta Genomics Ltd. provides therapeutic, diagnostic product development and medical research services. The company develops and commercializes new diagnostic tests based on various genomics markers, including DNA, microRNA and protein biomarkers and using various technologies, including, qPCR, microarrays, next generation sequencing and fluorescence in situ hybridization. It offers proprietary microRNA technologies, such as Rosetta Cancer Origin, mi-KIDNEY, and RosettaGX Reveal Test. The company was founded by Isaac Bentwich on March 9, 2000 and is headquartered in Rehovot, Israel.
---
Technical Analysis
---